ArticleFrontiers in medicine2025
Endometrial ablation as a safe treatment for adenomyosis-related abnormal uterine bleeding in women with cerebral infarction: a case report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adenomyosis is often associated with abnormal uterine bleeding (AUB), which can lead to anemia. Recurrent bleeding, especially in the presence of cerebral infarction risk, may exacerbate the likelihood of cerebral infarction through a hypercoagulable state. Although the relationship between adenomyosis and ischemic stroke is less frequently explored, controlling AUB and maintaining antithrombotic therapy remain clinical challenges. This report presents the application of endometrial ablation in a patient with adenomyosis, AUB, and cerebral infarction. Methods: We report a case of a 50-year-old female patient who developed acute ischemic stroke due to adenomyosis-related AUB. During the acute phase, the patient underwent endometrial ablation, successfully controlling the bleeding while continuing antiplatelet therapy. Results: After endometrial ablation, the patient's abnormal uterine bleeding was effectively controlled, with no recurrence of cerebral infarction. At a 37-month follow-up, the patient had no further vaginal bleeding or recurrence of cerebral infarction. Conclusion: This case is the first to report the use of endometrial ablation in a patient with adenomyosis and cerebral infarction, demonstrating the potential of this procedure in emergency hemostasis and maintaining antithrombotic therapy. Endometrial ablation is an effective, minimally invasive treatment with a quick recovery, making it a viable option for patients who cannot tolerate major surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.